Researchers at Lund University in Sweden, have in collaboration with colleagues in Copenhagen and Singapore, mapped how the body’s own peptides act to reduce infection and inflammation by deactivating the toxic substances formed in the process.
The study is published in Nature Communications and the researchers believe their discovery could lead to new drugs against infection and inflammation, for example in wound healing.
The toxins that are neutralised, known as lipopolysaccharides (LPS), come from the bacterial cell walls and generate an inflammatory reaction. The reaction is a necessary part of our immune defence system in which our bodies respond quickly and fight invasive bacteria. However, it can be over-activated and become harmful, as observed in infected skin wounds, infections in various organs, or in the case of bacteria spreading to the blood, which can lead to sepsis.
“We know from previous studies what the task of these peptides is but now we have mapped how they proceed in gradually reducing an inflammatory reaction”, says Artur Schmidtchen, professor of dermatology and venereology at Lund University and consultant physician at Skåne University Hospital in Lund.
“By use of advanced biophysics such as nuclear magnetic resonance analysis, combined with molecular modelling and biological studies we show that these peptides form a C-shaped structure which enables the capturing and inactivation of LPS. They also simultaneously interfere with receptor-mediated inflammatory responses”, adds Rathi Saravanan, senior research fellow at Lee Kong Chian School of Medicine at Nanyang Technological University, Singapore, and first author of the study.
“Currently, most drugs aim to more or less completely block a target, such as a receptor. But that risks a deactivation of the immune defence system which can be detrimental and downright dangerous. The body’s own defence mechanisms proceed with greater caution in what is known as a transient manner: the peptides act on their target for a short time to reduce an inflammation towards normalisation. It is the natural functions of these peptides that we want to develop into new drugs”, says Artur Schmidtchen, who has been researching the field of innate immunity for over 20 years.
In addition, the peptides present in thrombin, a common blood protein, are multifunctional and can attack several targets, unlike current drugs.
The dermatology researchers now want to develop a peptide gel for improved wound healing in patient studies.
“That is the primary goal, but we will also be looking at the possibility of developing new drugs against infections in the eyes and various internal organs. This will become a new way of preventing both infection and inflammation without using antibiotics.”
The Latest on: Peptides
via Google News
The Latest on: Peptides
- Peptide Therapeutics Market Size Estimated to Reach $48.2 Billion by 2026on July 6, 2021 at 2:44 pm
Peptide Therapeutics Market size is estimated to reach $48.2 billion by 2026, growing at a CAGR of 9.4% during the ...
- Amolyt Pharma Announces Hiring of Louis J. Arcudi III as Chief Financial Officeron July 6, 2021 at 5:08 am
Amolyt Pharma, a global company specializing in developing therapeutic peptides for rare endocrine and related diseases, today announced that the company has hired biotechnology senior executive Louis ...
- How Peptides Are Madeon July 4, 2021 at 5:01 pm
What does body building, anti-aging cream and Bleomycin (a cancer drug) have in common? Peptides of course! Peptides are large molecules that are vital to life. If you were to take a protein and ...
- Antimicrobial Peptides Market Competition landscape, Analysis of the Impact of COVID-19, Segmentation, Insights 2029on July 2, 2021 at 4:43 am
Antimicrobial Peptides market players - Eli Lilly and Company, Pfizer Inc., GlaxoSmithKline plc, Novartis International AG, EnBiotix Inc, among others represent the global Antimicrobial Peptides ...
- Fish Collagen Peptides Market to Set a High Potential Growth by 2020-2027on June 30, 2021 at 1:23 am
The global fish collagen peptides market is expected to grow from USD 271 million in 2019 to USD 509.08 million by 2027, at a CAGR of 8.2% during the forecast period 2020-2027.
- Cationic peptides inhibit SARS-CoV-2 cell entryon June 29, 2021 at 6:20 am
Two peptides generated by the group are termed G1 and G2 (LRSRTKIIRIRH and MPRRRRIRRRQK, respectively), the first of which possesses alternating positively charged residues, while G2 bears strings ...
- Geisinger peptide research could lead to new breast cancer treatmenton June 28, 2021 at 1:02 pm
DANVILLE —Geisinger announced research with peptides that disrupt proteins in a way that could become a safe treatment for breast cancer.
- Advances in intracellular spaces with de novo designed peptideon June 28, 2021 at 5:17 am
Scientists at Tokyo Institute of Technology (Tokyo Tech) have set out to harness the potential of self-assembling peptides (SAPs) in intracellular spaces. They present a de novo designed peptide, Y15, ...
via Bing News